Eli Lilly Strikes Deal with Govt Over COVID-19 Antibody Drug
Definitive Healthcare Makes Another Key Life Sciences Acquisition
Thermo Fisher Scientific Supports Direct-to-Patient Clinical Trials
AstraZeneca Resumes Phase 3 US Trial for its COVID-19 Vaccine
Bayer Inks $4B Pharma Acquisition Deal to Boost Gene Therapy Base
Johnson & Johnson Resumes Phase 3 Trial of COVID-19 Vaccine
HHS Guidance Further Expands Access to COVID-19 Vaccines, Tests
Roche, Atea Pharmaceuticals to Develop Oral COVID-19 Antiviral
Overcoming the Top Challenges of COVID-19 Vaccine Distribution
FDA Approves Remdesivir as the First COVID-19 Treatment
Purdue Pharmaceuticals Pleads Guilty in $8.3B Opioid Settlement
Combating Antimicrobial Resistance Through Global Market Reform
CRISPR’s CAR-T Cell Therapy Shows Promise in Clinical Trial
Thermo Fisher Scientific to Expand At-Home COVID-19 Testing
Sanofi’s mRNA COVID-19 Vaccine Elicits High Antibody Levels
NIH Launches Trial to Test Immune Modulator Drugs for COVID-19
Half of Black Americans Would Not Get the COVID-19 Vaccine
Roche Developing High-Volume COVID-19 Antigen Testing Product
10 of the Largest Pharmaceutical Companies by Revenue
AstraZeneca’s COVID-19 Antibody Advances into Phase 3 Trials
Bristol Myers Squibb’s MS Drug Helps Ulcerative Colitis Patients
HHS, DoD to Scale-Up Manufacturing of COVID-19 Antibody Cocktail
Eli Lilly Announces Supply Deal for COVID-19 Antibody Therapies
Johnson & Johnson Pauses COVID-19 Vaccine Clinical Trial
Pfizer Doses First Patient in Study on Hemophilia A Gene Therapy
COVID-19 Antibody Cocktail Reduces Viral Levels, Regeneron Says
Insulin Prices 8x Higher in the US Compared to Similar Nations
GSK, Vir Biotechnology Expand Phase 3 Study of COVID-19 Antibody
FDA Issues Guidance for Emergency Use of COVID-19 Vaccines
64% of New Drug Indications Lacked Pediatric Prescribing Info
Johnson & Johnson Completes $6.5B Pharma Acquisition Deal
Major Pharma Companies Support Global Access to COVID-19 Vaccine
Hospitals Go Back to Purchasing Remdesivir from Distributor
HHS to Share Best Practices for Point-of-Care COVID-19 Testing
Abbott Enrolls First Patient in Spinal Cord Stimulation Study
CDC to Dole Out $200M for COVID-19 Vaccine Preparedness
Older Adults Likely to be Excluded from COVID-19 Vaccine Trials
ViiV Healthcare Launches Injectable HIV Treatment Study